Dashboard
Manage Tickers

TBPH Theravance Biopharma, Inc.

Nasdaq theravance.com


$ 17.36 $ -0.56 (-3.12 %)    

Friday, 14-Nov-2025 15:54:50 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 17.39
$ 17.49
$ 17.38 x 10
$ 17.42 x 100
$ 17.34 - $ 17.75
$ 7.90 - $ 18.96
474,918
na
881.19M
$ 0.65
$ 30.03
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-13-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-07-2025 01-01-1970 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-15-2024 03-31-2024 10-Q
8 03-01-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-05-2019 06-30-2019 10-Q
27 05-10-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 02-28-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-11-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
11/11/2025 17:09:17

hc-wainwright--co-maintains-buy-on-theravance-biopharma-raises-price-target-to-20
HC Wainwright & Co. Maintains Buy on Thera...
11/11/2025 12:26:44

HC Wainwright & Co. analyst Douglas Tsao maintains Theravance Biopharma (NASDAQ:TBPH) with a Buy and raises the price ta...

theravance-biopharma-q3-eps-007-beats-013-estimate-sales-19990m-beat-19960m-estimate
Theravance Biopharma Q3 EPS $0.07 Beats $(...
11/10/2025 21:08:28

Theravance Biopharma (NASDAQ:TBPH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of ...

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

theravance-biopharma-to-present-ampreloxetine-nohmsa-data-in-four-presentations-at-36th-aas-autonomic-symposium-nov-58-clearwater-beach-fl-phase-3-cypress-topline-due-q1-2026
Theravance Biopharma To Present Ampreloxet...
10/29/2025 10:14:42

paccar-posts-downbeat-earnings-joins-neuphoria-therapeutics-citius-pharmaceuticals-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
PACCAR Posts Downbeat Earnings, Joins Neup...
10/21/2025 12:16:10

why-crown-holdings-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket
Why Crown Holdings Shares Are Trading High...
10/21/2025 09:46:14

theravance-biopharma-will-be-presenting-at-chest-2025-the-annual-meeting-of-the-american-college-of-chest-physicians
Theravance Biopharma Will Be Presenting At...
10/14/2025 10:05:49

A retrospective cohort study of claims data demonstrated that following hospital discharge, patients adherent to YUPELRI experi...

this-protagonist-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-friday
This Protagonist Therapeutics Analyst Begi...
09/12/2025 12:37:17

b-riley-securities-initiates-coverage-on-theravance-biopharma-with-buy-rating-announces-price-target-of-28
B. Riley Securities Initiates Coverage On ...
09/12/2025 09:33:16

B. Riley Securities analyst Mayank Mamtani initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Buy rating and an...

theravance-biopharma-completes-enrollment-in-pivotal-phase-3-trial-for-blood-pressure-disorder-advances-phase-3-cypress-study-targeting-rare-neurodegenerative-disease-affecting-msa-patients
Theravance Biopharma Completes Enrollment ...
08/25/2025 10:05:40

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ:TBPH), today announced completion ...

theravance-and-mylan-entered-settlement-agreement-with-cipla-over-yupelri-revefenacin-inhalation-solution
Theravance and Mylan Entered Settlement Ag...
08/20/2025 10:20:24

theravance-biopharma-q2-adj-eps-008-beats-017-estimate-sales-26195m-beat-22437m-estimate
Theravance Biopharma Q2 Adj. EPS $(0.08) B...
08/12/2025 20:10:32

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of ...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

btig-maintains-buy-on-theravance-biopharma-raises-price-target-to-25
BTIG Maintains Buy on Theravance Biopharma...
06/27/2025 14:58:40

BTIG analyst Julian Harrison maintains Theravance Biopharma (NASDAQ:TBPH) with a Buy and raises the price target from $24 to...

theravance-biopharma-scores-75m-milestone-after-yupelri-inhalation-solution-approved-in-china-for-copd-treatment
Theravance Biopharma Scores $7.5M Mileston...
06/26/2025 10:02:56

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ:TBPH) today announced that Viatris...

Core News & Articles
This Coinbase Global Analyst Begins Covera...
06/17/2025 13:24:58

jones-trading-initiates-coverage-on-theravance-biopharma-with-buy-rating-announces-price-target-of-24
Jones Trading Initiates Coverage On Therav...
06/17/2025 11:10:14

Jones Trading analyst Debanjana Chatterjee initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Buy rating and an...

Core News & Articles
Theravance, Mylan Reach Settlement With Eu...
06/06/2025 10:08:54

theravance-biopharma-presents-analyses-of-previous-phase-3-program-evaluating-ampreloxetine-for-treatment-of-symptomatic-noh-at-international-msa-congress
Theravance Biopharma Presents Analyses Of ...
05/09/2025 16:03:43

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ:TBPH) today announced presentation...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION